Wikipedia -WSS

Wikipedia

author：comprehensive 2025-08-08 20:56:13 - browse：4298

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Editas, Vertex strike deal on CRISPR

focus

WSS

Grail spinoff by Illumina should end disastrous merger attempt

Caribou posts encouraging results on off

5 dead in mass shooting on Caribbean island of St. Vincent: Police

A new ‘biological computer' targets cancer while sparing healthy cells

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

entertainment

Wikipedia

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

SNAP should offer more nutrition education

Guidelines to prevent youth baseball injuries need more muscle

Caribou posts encouraging results on off

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Christmas in the PICU brings some surprising joy

ChatGPT in medicine: STAT answers readers' burning questions

After a decade, new Gardasil ad campaign gets it (mostly) right

Walensky prepares to leave CDC — and Congress — behind

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

focus

David Ricks of Eli Lilly: best biopharma CEO of 2023

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Dementia risk linked to living in disadvantaged areas: Study

Sanders wants to replace patents with prizes for drug inventions

Bristol Myers buys into radiopharmaceuticals with RayzeBio

focus

focus

focus

focus